Consun Pharmaceutical Group Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 141,000 ordinary shares at a total aggregate price of HKD 2,111,830. The repurchased shares were acquired for cancellation under the company's existing repurchase mandate.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952752), on December 11, 2025, and is solely responsible for the information contained therein.
Comments